Literature DB >> 954759

Therapeutic properties.of haemodialysis and blood exchange transfusion in organophosphate poisoning.

S Okonek, G Boelcke, H Hollmann.   

Abstract

Human blood was contaminated with nitrostigmine, dimethoate and demeton-S-methyl sulfoxide. It was then dialysed, concentrations of organophosphates were determined and dialysance values calculated. The influence of blood exchange transfusion on poison elimination as well as on the cholinesterase activity of blood, brain and muscle was studied in rats poisoned with nitrostigmine. Haemodialysis was found to be quite an effective method for eliminating demeton-S-methyl sulfoxide and dimethoate, dialysance values of 52.98 ml/min and 59.07 ml/min being found for demeton-S-methyl sulfoxide and dimethoate respectively. Nitrostigmine could not be removed by haemodialysis. These findings suggest that haemodialysis could be of therapeutic value in the treatment of severe demeton-S-methyl sulfoxide and dimethoate poisoning in man. By blood exchange transfusion only 0.06% of the injected dose of nitrostigmine could be removed from the body of poisoned rats. Acetylcholinesterase activity increased only briefly in the period of blood exchange transfusion and decreased gradually afterwards. The enzymatic activity of brain and muscle was unaffected. Therefore, blood exchange transfusion has, if any at all, only poor therapeutic properties in nitrostigmine intoxication.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954759     DOI: 10.1007/BF00571891

Source DB:  PubMed          Journal:  Eur J Intensive Care Med        ISSN: 0340-0964


  21 in total

1.  [Current viewpoints in alkylphosphate poisoning. Biochemical findings, symptoms and therapy].

Authors:  S Okonek
Journal:  Internist (Berl)       Date:  1975-03       Impact factor: 0.743

2.  FERROUS-SULPHATE POISONING TREATED BY EXCHANGE TRANSFUSION.

Authors:  B TOMLINSON
Journal:  Lancet       Date:  1964-11-07       Impact factor: 79.321

3.  Effect of Paraoxon and antidotes on lipolysis of isolated fat cells.

Authors:  H D Peters; P Selhorst; V Dinnendahl; K U Helm; P S Schöndhöfer
Journal:  Arch Toxikol       Date:  1973

4.  [Kinetics of aminophenazone-clearance through blood exchange. A case of combined aminophenazone-phenylbutazone intoxication in a child].

Authors:  A Windorfer; R Gädeke; F Schindera
Journal:  Arch Toxikol       Date:  1973-03-28

5.  Comparison of haemoperfusion and haemodialysis in the therapy of barbiturate intoxication in dogs.

Authors:  R K Medd; B Widdop; R A Braithwaite; A J Rees; R Goulding
Journal:  Arch Toxikol       Date:  1973

Review 6.  Deaths from phosphostigmine poisoning in Denmark. An analysis of the medico-social and medico-legal aspects.

Authors:  E Juhl
Journal:  Dan Med Bull       Date:  1971-01

7.  [Severe poisoning with the insecticide Metasystox R].

Authors:  R Goebel; R Zeichen; W Giessauf
Journal:  Wien Med Wochenschr       Date:  1969-09-27

8.  The mode of action of cholinesterase inhibitors on the temperature regulation of the rat.

Authors:  E Meeter
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-12

9.  Hemodialysis in the treatment of poisoning by methylparathion.

Authors:  G Gál; L Simon; B Rengei; L Mindszenty; M Ember
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1970-07

10.  [Treatment of parathion (E 605) poisoning with the cholinesterase-reactivating substance obidoxime (Toxogonin)].

Authors:  D Barckow; G Neuhaus; W D Erdmann
Journal:  Arch Toxikol       Date:  1969
View more
  4 in total

Review 1.  Efforts toward treatments against aging of organophosphorus-inhibited acetylcholinesterase.

Authors:  Qinggeng Zhuang; Amneh Young; Christopher S Callam; Craig A McElroy; Özlem Dogan Ekici; Ryan J Yoder; Christopher M Hadad
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

2.  Hemoperfusion in severe dimethoate poisoning.

Authors:  C Köppel; Z Forycki; K Ibe
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

3.  Toxicokinetics of methyl parathion and parathion in the dog after intravenous and oral administration.

Authors:  R A Braeckman; F Audenaert; J L Willems; F M Belpaire; M G Bogaert
Journal:  Arch Toxicol       Date:  1983-09       Impact factor: 5.153

Review 4.  Clinical review: timing of renal replacement therapy.

Authors:  Michael Joannidis; Lui G Forni
Journal:  Crit Care       Date:  2011-06-10       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.